Processing of IVIg may affect safety, efficacy, and adverse events.(Dermatologic Therapy): An article from: Skin & Allergy News

This digital document is an article from Skin & Allergy News, published by International Medical News Group on May 1, 2004. The length of the article is 605 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Processing of IVIg may affect safety, efficacy, and adverse events.(Dermatologic Therapy)
Author: Jeff Evans
Publication:Skin & Allergy News (Magazine/Journal)
Date: May 1, 2004
Publisher: International Medical News Group
Volume: 35 Issue: 5 Page: 36(1)

Distributed by Thomson Gale